OBJECTIVE: The slit homologue 2 (SLIT2) gene is a tumour suppressor gene. This study investigated the methylation status of the SLIT2 promoter in women with ovarian cancer in terms of identifying whether this might aid the early diagnosis of ovarian cancer. METHODS: Using methylation-specific polymerase chain reaction analysis, the methylation status of the SLIT2 promoter was measured in tumour tissue and serum samples from 36 patients with ovarian cancer and in matched serum samples from 25 controls without cancer. RESULTS: Aberrant methylation of the SLIT2 promoter was present in ovarian tissue from 29/36 (80.6%) ovarian cancer patients, but not in the 25 healthy controls. Among the cases with hypermethylation in their ovarian tissue, 27/29 (93.1%) of the case-matched serum DNA samples, including all four cases of early-stage ovarian cancer, showed hypermethylation of the SLIT2 promoter. CONCLUSIONS: Hypermethylation of the SLIT2 promoter may be a relatively early event in ovarian cancer; thus, its detection may be an effective approach to improve early diagnosis.
JemalASiegelRXuJ: Cancer statistics, 2010. CA Cancer J Clin2010; 60: 277–300.
2.
ShenK: Problems in connection to treatment of ovarian tumours and fertility preservation. Zhonghua Fu Chan Ke Za Zhi2003; 38: 489–492 [in Chinese].
3.
YuJCaoQYuJ: The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene2010; 29: 5370–5380.
4.
MarlowRStricklandPLeeJS: SLITs suppress tumour growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res2008; 68: 7819–7827.
5.
TsengRCLeeSHHsuHS: SLIT2 attenuation during lung cancer progression deregulates β-catenin and E-cadherin and associates with poor prognosis. Cancer Res2010; 70: 543–551.
6.
YiinJJHuBJarzynkaMJ: Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol2009; 11: 779–789.
7.
XuYLiWLFuL: Slit2/Robo1 signaling in glioma migration and invasion. Neurosci Bull2010; 26: 474–478.
8.
GeorgasKBurridgeLSmithK: Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2. Cytogenet Cell Genet1999; 86: 246–247.
9.
DallolAMortonDMaherER: SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res2003; 63: 1054–1058.
10.
JinJYouHYuB: Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Biochem Biophys Res Commun2009; 379: 86–91.
11.
SinghRKIndraDMitraS: Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumour suppressor gene. Hum Genet2007; 122: 71–81.
12.
DallolADa SilvaNFViacavaP: SLIT2, a human homologue of the Drosophila Slit2 gene, has tumour suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res2002; 62: 5874–5880.
13.
EllingerJAlbersPPeraboFG: CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J Urol2009; 182: 324–329.
14.
YangHJLiuVWWangY: Detection of hypermethylated genes in tumour and plasma of cervical cancer patients. Gynecol Oncol2004; 93: 435–440.
15.
MüllerHMFieglHWidschwendterA: Prognostic DNA methylation marker in serum of cancer patients. Ann N Y Acad Sci2004; 1022: 44–49.
16.
HermanJGGraffJRMyöhänenS: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA1996; 93: 9821–9826.
17.
JonesPA: DNA methylation and cancer. Oncogene2002; 21: 5358–5360.
18.
MorrisMRHessonLBWagnerKJ: Multigene methylation analysis of Wilms’ tumour and adult renal cell carcinoma. Oncogene2003; 22: 6794–6801.
19.
LalGPadmanabhaLProvenzanoM: Regulation of 14-3-3 expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation. Cancer Lett2008; 267: 165–174.
20.
ZhangQYingJZhangK: Aberrant methylation of the 8p22 tumour suppressor gene DLC1 in renal cell carcinoma. Cancer Lett2007; 249: 220–226.
21.
MittagFKuesterDViethM: DAPK promotor methylation is an early event in colorectal carcinogenesis. Cancer Lett2006; 240: 69–75.
22.
de CaceresI IbanezBattagliCEstellerM: Tumour cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res2004; 64: 6476–6481.
23.
UsadelHBrabenderJDanenbergKD: Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res2002; 62: 371–375.
24.
KawakamiKBrabenderJLordRV: Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst2000; 92: 1805–1811.
25.
QiuHZhuJYuJ: SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated. Asian Pac J Cancer Prev2011; 12: 791–795.
